Crusekitug
Crusekitug is a humanized monoclonal antibody targeting human interleukin 17A (IL-17A) . Crusekitug specifically binds to IL-17A, blocking its signal transduction, thus exerting immunosuppressive and anti-inflammatory activities. Crusekitug is promising for research of autoimmune and inflammatory diseases, such as psoriasis and rheumatoid arthritis[1].
Product Specifications
CAS Number
[2956768-50-4]
Product Name Alternative
QX-002N
UNSPSC
12352203
Target
Interleukin Related
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Smiles
[Crusekitug]
References & Citations
[1]World Health Organization. WHO Drug Information: Volume 38[M]. World Health Organization, 2024.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Isoform
IL-17
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
